Patterns of neutrophil serine protease-dependent cleavage of surfactant protein D in inflammatory lung disease

Jessica Cooley1, Barbara McDonald, Frank J Accurso

  • 1Immune Disease Institute, Harvard Medical School, Boston, MA 02115, USA.

Insights

Neutrophil elastase significantly depletes surfactant protein D (SP-D) in cystic fibrosis (CF) lung fluids. Calcium levels influence SP-D fragmentation by neutrophil serine proteases (NSPs), with elastase being the primary enzyme involved.

Area of Science:

  • Pulmonary Medicine
  • Biochemistry
  • Immunology

Background:

  • Surfactant protein D (SP-D) plays a crucial role in lung innate immunity.
  • SP-D levels are altered in inflammatory lung diseases like cystic fibrosis (CF).
  • Neutrophil serine proteases (NSPs) are implicated in lung tissue degradation during inflammation.

Purpose of the Study:

  • To investigate the role of NSPs in SP-D depletion in CF bronchoalveolar lavage fluid (BALF).
  • To identify novel SP-D fragments and cleavage sites generated by NSPs.
  • To determine the influence of calcium concentration on SP-D fragmentation by NSPs.

Main Methods:

  • Analysis of SP-D in BALF from children with CF.
  • Isoelectrofocusing, modified blotting, and region-specific antibodies for fragment identification.
  • In vitro cleavage of recombinant human SP-D by NSPs at varying calcium concentrations.

Main Results:

  • SP-D depletion in CF BALF correlates with active neutrophil elastase.
  • Novel 27 kDa and 11 kDa C-terminal SP-D fragments were identified, alongside a 35 kDa N-terminal fragment.
  • SP-D fragmentation patterns by NSPs are calcium-dependent, with different fragments generated at low versus physiological calcium levels.
  • Elastase is the most potent NSP for SP-D cleavage, followed by proteinase-3 and cathepsin G.

Conclusions:

  • Neutrophil elastase is the primary protease responsible for SP-D depletion in inflammatory lung diseases.
  • Calcium concentration modulates the specific cleavage of SP-D by NSPs.
  • Understanding SP-D fragmentation provides insights into lung inflammatory processes.

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...